Inhibition by saccharides of the agglutination of periodate-treated erythrocytes by horse serum  by Novogrodsky, Abraham
Volume 19, number 2 FEBS LETTERS December 1971 
INHIBITION BY SACCHARIDES OF THE AGGLUTINATION OF 
PERIODATE-TREATED ERYTHROCYTES BY HORSE SERUM 
Abraham NOVOGRODSKY 
Department of Biophysics, The Weizmann Institute of Science, Rehovot, Israel 
Received 17 September 197 1 
1. Introduction 
Human erythrocytes after treatment with sodium 
periodate (NaIO,) are rendered agglutinable by all 
adult human sera tested [ 1,2] , and by sera from 
other mammalian species [3] . The agglutinin for 
NaIO,-treated erythrocytes (P-agglutinin) was 
characterized as a 19 S macroglobulin [4] . Further 
studies [ 1,2] have shown that treatment of human 
erythrocytes with NaIO, modified their antigenic 
properties. We report here on the inhibition by specific 
saccharides of the agglutination of NaIO,-treated cry- 
throcytes by the P-agglutinin present in horse serum. 
2. Materials and methods 
2.1. Materials 
Horse serum was obtained from Grand Island Bio- 
logical Co., USA, and was incubated for 30 min at 56” 
prior to its use. Sodium periodate, analytical reagent, 
was obtained from BDH Chemicals Ltd., England. 
Saccharides were obtained from Pfanstiehl Laborato- 
ries, Inc., Illinois. 
2.2. Treatment of erythrocytes with NaIO, 
Washed human or rat erythrocytes were suspended 
(16 X lo6 /ml) in phosphate buffered saline (PBS) [5] , 
containing NaIO, (4 X 10e4 M) and incubated for 10 
min at room temp. The cells were then centrifuged 
and washed 3 times with 100 volumes of PBS and 
suspended in the same buffer. 
2.3. Agglutination assay 
The agglutination assay system contained in a total 
North-Holland Publishing Company - Amsterdam 
volume of 0.6 ml: 0.4 ml of NaIO,-treated erythro- 
cytes (12 S X 1 O6 /ml in PBS), 0.1 ml of horse serum 
diluted in PBS and 0.1 ml of saccharide (200 mg/ml 
in PBS). The extent of the agglutination was estimated 
by determining the percentage of single cells remaining 
in the incubation mixture after incubation at room 
temp. for 2 hr and 10 hr. 
3. Results and discussion 
The effect of several saccharides on the agglutina- 
tion of human erythrocytes by horse serum is shown 
in table 1. The results obtained showed that N-acetyl- 
D-glucosamine and N-acetyl-D-galactosamine, marked- 
ly inhibited the agglutination of NaIO,-treated ery- 
throcytes by horse serum. A much lesser degree of in- 
hibition was obtained with some of the other sacchar- 
ides tested. Similar results were obtained when NaIO,- 
treated human erythrocytes of type 0, human ery- 
throcytes of type A or rat erythrocytes were used. 
The site of action of NaIO, on the cell membrane 
is not known. However, it is most plausible that NaIO, 
exerts its effect by oxidizing carbohydrate moieties 
in the cell membrane. It is thus possible that in the 
chemically modified membrane new sites are exposed 
which are capable of interacting with the P-agglutinin 
present in horse serum. N-acetyl-D-glucosamine and 
N-acetyl-D-galactosamine, most likely, inhibit the 
agglutination of NaIO, -treated erythrocytes as a 
result of a competitive inhibition reaction in which 
the above mentioned saccharides and the membrane 
sites exposed by NaIO,-treatment compete for the 
binding sites of the P-agglutinin. Uhlenbruck and 
Wintzer [6] recently reported the appearance of new 
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Table 1 
Effect of saccharides onthe agglutination of NaIOd-treated human erythrocytes by horse serum. 
Saccharide added 
Percentage of single cells remaining after 
2 hr 10hr 
final dilution of horse serum 
1:40 1:80 1:160 j 1:40 1:80 1:160 
None 
D-Glucose 
D-Galactose 
D-Mannose 
L-Fucose 
Methyl-cu-D-mannopyranoside 
N-Acetyl-D-glucosamine 
N-Acetyl-D-galactosamine 
4 15 23 1 4 12 
4 25 29 2 I 12 
9 10 34 3 3 19 
14 29 31 6 9 9 
13 32 49 2 I 6 
3 16 51 0 4 32 
43 92 98 19 87 96 
25 94 95 _ 85 - 
Agglutination assays were performed as described in Materials and methods. NaIOa-treated human erythrocytes of type A were 
used. 
terminal sugars in erythrocytes after enzymatic 
removal of neuraminic acid. It is pertinent to note 
that treatment of erythrocytes with neuraminidase, 
similarly to treatment with NaI04, renders the cells 
panagglutinable [7] However, the sites exposed by 
the two different treatments can be differentiated 
serologically [ 1,2] . 
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